Market Overview:
The global single cell genomics market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for single cell genomic analysis for understanding the genomic variation, subpopulation characterization, and circulating tumor cells (CTCs). In addition, technological advancements in single cell genomics are also contributing to the growth of this market. Based on type, the global single cell genomics market is segmented into cell isolation, sample preparation, and genomic analysis. The sample preparation segment is further divided into purification and enrichment techniques. The purification techniques include centrifugation methods such as density gradient centrifugation and immuno-magnetic separation; while enrichment techniques include fluorescence activated cell sorting (FACS) and magnetic activated Cell sorting (MACS). On the basis of application, the global single cell genomics market is segmented into genomic variation, subpopulation characterization CTCs),cell differentiation ,and others .Geographically ,the global Single Cell Genomic Marketis dividedinto North America,, Latin America,, Europe Asia Pacificand Middle East & Africa . (U.S.), Thermo Fisher Scientific Inc.(U.S.), QIAGEN N.V.
Product Definition:
Single Cell Genomics is the study of the genome and epigenome of a single cell. The importance of Single Cell Genomics is that it can provide insights into the genetic and epigenetic variability of cells within a population. This can be used to understand how cells develop, how they respond to stimuli, and how they contribute to disease.
Cell Isolation:
Cell isolation is a process to remove one or more cells from their surrounding matrix and/or culture medium. It can be used for various applications such as research, diagnostics, drug discovery & development, cell therapy etc. The main purpose of this process is to maintain the purity of the isolated cell or cells and analyze them in vitro chemically and physically.
Sample Preparation:
The process of sample preparation is used to reduce the complexity of DNA or RNA samples and make them amenable for further analysis. The steps involved in sample preparation include physical, chemical, and enzymatic treatments. Physical treatment includes removal of cellular debris using filtration methods such as magnetic bead-based isolation or protein A purification. Chemical treatment involves conversion of proteins into amino acids for easier digestion by enzymes.
Application Insights:
Genomic variation dominated the overall industry in terms of revenue share in 2017. This is attributed to the rising prevalence of cancer and increasing demand for its treatment across various regions, including North America, Europe, Asia Pacific and Middle East & Africa. Moreover, a rise in research activities pertaining to Single Cell Genomics has led to an increase in demand for sequencing capabilities that enable rapid detection of genetic abnormalities which may otherwise go undetected.
Circulating tumor cells (CTC) characterization segment is expected to grow at a lucrative rate during the forecast period owing to growing awareness about CTCs as a potential biomarker for cancer diagnosis and their application as a therapeutic target. In addition, there are ongoing clinical trials that focus on CTCs as therapeutic targets which will further boost market growth over the coming years.
Regional Analysis:
North America dominated the global single cell genomics market in 2016 owing to the presence of a substantial number of academic and research institutes involved in cancer, infectious disease, developmental biology, neuroscience and other areas. Moreover, these institutes are continuously working on projects that involve analysis of single cells for gaining deeper insights into various biological processes. Thus all these factors have contributed to North America’s dominance in this industry.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing focus on basic research activities across several Asian countries coupled with rising healthcare expenditure levels by governments as well as private organizations.
In addition it must be noted that China holds more than 10% share within Asia Pacific genomic medicine market due its low cost associated with genomic tests development compared with developed economies such as U.S.
Growth Factors:
- Increasing demand for single cell genomics in life science research for understanding the biology of individual cells
- Advances in technology and instrumentation that enable more efficient and accurate sequencing of single cells
- Growing interest in using single cell genomics to study cancer and other diseases
- Increasing use of single cell genomics data in drug discovery and development
- Expansion of the market into new applications such as agricultural biotechnology
Scope Of The Report
Report Attributes
Report Details
Report Title
Single Cell Genomics Market Research Report
By Type
Cell Isolation, Sample Preparation, Genomic Analysis
By Application
Genomic Variation, Subpopulation Characterization, Circulating Tumor Cells, Cell Differentiation, Others
By Companies
X Genomics, Accelerate Diagnostics, Affymetrix, Agilent Technologies, Celsee Diagnostics, Denovo Sciences, DNA Electronics, Enumeral Biomedical, Epic Sciences, Kellbenx, Qiagen, Resolution Bioscience, Thermo Fisher Scientific, Wafergen Bio-Systems, Yikon Genomics, Zephyrus Biosciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Single Cell Genomics Market Report Segments:
The global Single Cell Genomics market is segmented on the basis of:
Types
Cell Isolation, Sample Preparation, Genomic Analysis
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Genomic Variation, Subpopulation Characterization, Circulating Tumor Cells, Cell Differentiation, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- X Genomics
- Accelerate Diagnostics
- Affymetrix
- Agilent Technologies
- Celsee Diagnostics
- Denovo Sciences
- DNA Electronics
- Enumeral Biomedical
- Epic Sciences
- Kellbenx
- Qiagen
- Resolution Bioscience
- Thermo Fisher Scientific
- Wafergen Bio-Systems
- Yikon Genomics
- Zephyrus Biosciences
Highlights of The Single Cell Genomics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Isolation
- Sample Preparation
- Genomic Analysis
- By Application:
- Genomic Variation
- Subpopulation Characterization
- Circulating Tumor Cells
- Cell Differentiation
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Single Cell Genomics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Single Cell Genomics is the study of genomes within single cells. This technology can be used to identify and characterize the genetic makeup of individual cells, which can then be used to better understand how these cells function and interact with one another.
Some of the key players operating in the single cell genomics market are X Genomics, Accelerate Diagnostics, Affymetrix, Agilent Technologies, Celsee Diagnostics, Denovo Sciences, DNA Electronics, Enumeral Biomedical, Epic Sciences, Kellbenx, Qiagen, Resolution Bioscience, Thermo Fisher Scientific, Wafergen Bio-Systems, Yikon Genomics, Zephyrus Biosciences.
The single cell genomics market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Single Cell Genomics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Single Cell Genomics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Single Cell Genomics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Single Cell Genomics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Single Cell Genomics Market Size & Forecast, 2020-2028
4.5.1 Single Cell Genomics Market Size and Y-o-Y Growth
4.5.2 Single Cell Genomics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cell Isolation
5.2.2 Sample Preparation
5.2.3 Genomic Analysis
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Genomic Variation
6.2.2 Subpopulation Characterization
6.2.3 Circulating Tumor Cells
6.2.4 Cell Differentiation
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Single Cell Genomics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Single Cell Genomics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cell Isolation
9.6.2 Sample Preparation
9.6.3 Genomic Analysis
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Genomic Variation
9.10.2 Subpopulation Characterization
9.10.3 Circulating Tumor Cells
9.10.4 Cell Differentiation
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cell Isolation
10.6.2 Sample Preparation
10.6.3 Genomic Analysis
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Genomic Variation
10.10.2 Subpopulation Characterization
10.10.3 Circulating Tumor Cells
10.10.4 Cell Differentiation
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cell Isolation
11.6.2 Sample Preparation
11.6.3 Genomic Analysis
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Genomic Variation
11.10.2 Subpopulation Characterization
11.10.3 Circulating Tumor Cells
11.10.4 Cell Differentiation
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cell Isolation
12.6.2 Sample Preparation
12.6.3 Genomic Analysis
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Genomic Variation
12.10.2 Subpopulation Characterization
12.10.3 Circulating Tumor Cells
12.10.4 Cell Differentiation
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cell Isolation
13.6.2 Sample Preparation
13.6.3 Genomic Analysis
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Genomic Variation
13.10.2 Subpopulation Characterization
13.10.3 Circulating Tumor Cells
13.10.4 Cell Differentiation
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Single Cell Genomics Market: Competitive Dashboard
14.2 Global Single Cell Genomics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 X Genomics
14.3.2 Accelerate Diagnostics
14.3.3 Affymetrix
14.3.4 Agilent Technologies
14.3.5 Celsee Diagnostics
14.3.6 Denovo Sciences
14.3.7 DNA Electronics
14.3.8 Enumeral Biomedical
14.3.9 Epic Sciences
14.3.10 Kellbenx
14.3.11 Qiagen
14.3.12 Resolution Bioscience
14.3.13 Thermo Fisher Scientific
14.3.14 Wafergen Bio-Systems
14.3.15 Yikon Genomics
14.3.16 Zephyrus Biosciences
